The DUR Board provides an evaluation of criteria for drug coverage within Texas Medicaid. These criteria are used in retrospective and prospective drug utilization review, and are based on the compendia and peer-reviewed medical literature. Criteria and standards are periodically revised to ensure that they reflect prescribing recommendations of the current compendia and literature.

  1. Acetylcholinesterase Inhibitors (PDF)
  2. Aerosolized Agents - metered-dose inhalers: anti-cholinergic drugs (PDF)
  3. Aerosolized Agents - Metered-Dose Inhalers: Anti-inflammatory Drugs (PDF)
  4. Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (long-acting) (PDF)
  5. Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (short-acting) (PDF)
  6. Angiotensin-Converting Enzyme Inhibitors (PDF)
  7. Angiotensin II Receptor Blockers (PDF)
  8. Anti-depressants, oral (other) (PDF)
  9. Anti-depressants, selective serotonin reuptake inhibitors (PDF)
  10. Anti-diabetic Agents (oral) (PDF)
  11. Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder Medications (PDF)
  12. Atypical Anti-psychotics (long-acting injectable) (PDF)
  13. Atypical Anti-psychotics (oral) (PDF)
  14. Benzodiazepines (oral, rectal) (PDF)
  15. Complement Inhibitor and Enzyme/Protein Replacement Therapy (PDF)
  16. Cyclooxygenase-2 Inhibitors (PDF)
  17. Direct Oral Anticoagulants (PDF)
  18. Exogenous Insulin Products (PDF)
  19. Fentanyl (PDF)
  20. Fluoroquinolones (oral) (PDF)
  21. Gabapentin (PDF)
  22. Glucagon-like Peptide 1 Receptor Agonists (PDF)
  23. Histamine H2 - Receptor Antagonists (PDF)
  24. Hydroxy-Methylglutaryl Coenzyme A Reductase Inhibitors (PDF)
  25. Hydrocodone Bitartrate/Hydrocodone Polistirex (PDF)
  26. Immune Globulins (PDF)
  27. Ivacaftor (Kalydeco) and Lumacaftor/Ivacaftor (Orkambi) (PDF)
  28. Ketorolac (oral) (PDF)
  29. Leukotriene Receptor Antagonists (PDF)
  30. Low Molecular - Weight Heparins (PDF)
  31. Mecasermin (PDF)
  32. Memantine (PDF)
  33. Nebulized Bronchodilators (PDF)
  34. Nitazoxanide (PDF)
  35. Non-sedating Antihistamines (PDF)
  36. Non-steroidal anti-inflammatory drugs (PDF)
  37. Platelet Aggregation Inhibitors (PDF)
  38. Pramlintide (PDF)
  39. Promethazine Use In Children Less Than 2 Years of Age (PDF)
  40. Proton Pump Inhibitors (PDF)
  41. Quetiapine (low dose) (PDF)
  42. Rifaximin (Xifaxan) (PDF)
  43. Sedative/Hypnotics (PDF)
  44. Serotonin 5-HT1B/1D Receptor Agonists (PDF)
  45. Serotonin 5-HT3 Receptor Antagonists for Nausea and Vomiting (oral) (PDF)
  46. Sickle Cell Disease Products (PDF)
  47. Skeletal Muscle Relaxants (PDF)
  48. Substance P/Neurokinin1 Receptor Antagonists (PDF)
  49. Topical Calcineurin Inhibitors - Pimecrolimus (Elidel) and Tacrolimus (Protopic) (PDF)
  50. Tramadol (PDF)